PMID- 37804391
OWN - NLM
STAT- MEDLINE
DCOM- 20231129
LR  - 20240419
IS  - 1534-3170 (Electronic)
IS  - 1523-3782 (Linking)
VI  - 25
IP  - 11
DP  - 2023 Nov
TI  - Endovascular Interventions for Peripheral Artery Disease: A Contemporary Review.
PG  - 1611-1622
LID - 10.1007/s11886-023-01973-9 [doi]
AB  - PURPOSE OF REVIEW: Peripheral artery disease (PAD) is an increasingly prevalent 
      but frequently underdiagnosed condition that can be associated with high rates of 
      morbidity and mortality. While an initial noninvasive approach is the cornerstone 
      of management, revascularization is often pursued for patients with 
      treatment-refractory claudication or chronic limb-threatening ischemia (CLTI). In 
      this review, we discuss the current state of endovascular interventions for PAD 
      and explore the many new emerging technologies. RECENT FINDINGS: The last decade 
      has resulted in numerous advances in PAD interventions including the ongoing 
      evolution of drug-coated devices, novel approaches to complex lesions, and 
      contemporary evidence from large clinical trials for CLTI. Advances in 
      endovascular management have allowed for increasingly complex lesions to be 
      tackled percutaneously. Future directions for the field include the continued 
      evolution in device technology, continued development of state-of-the-art 
      techniques to revascularization of complex lesions, and increased collaboration 
      between a largely multidisciplinary field.
CI  - (c) 2023. The Author(s), under exclusive licence to Springer Science+Business 
      Media, LLC, part of Springer Nature.
FAU - Watson, Nathan W
AU  - Watson NW
AD  - Harvard Medical School, Boston, MA, USA.
AD  - Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, 
      Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
FAU - Mosarla, Ramya C
AU  - Mosarla RC
AD  - Division of Cardiology, Department of Medicine, New York University Medical 
      Center, New York, NY, USA.
FAU - Secemsky, Eric A
AU  - Secemsky EA
AD  - Harvard Medical School, Boston, MA, USA. esecemsk@bidmc.harvard.edu.
AD  - Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, 
      Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. 
      esecemsk@bidmc.harvard.edu.
AD  - Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical 
      Center, Boston, MA, USA. esecemsk@bidmc.harvard.edu.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20231007
PL  - United States
TA  - Curr Cardiol Rep
JT  - Current cardiology reports
JID - 100888969
SB  - IM
MH  - Humans
MH  - Risk Factors
MH  - *Endovascular Procedures/methods
MH  - Treatment Outcome
MH  - *Peripheral Arterial Disease/surgery/diagnosis
MH  - Intermittent Claudication/therapy
MH  - Ischemia/therapy
MH  - Limb Salvage/methods
MH  - Retrospective Studies
MH  - Chronic Disease
OTO - NOTNLM
OT  - Chronic limb-threatening ischemia
OT  - Claudication
OT  - Endovascular therapy
OT  - Peripheral artery disease
EDAT- 2023/10/07 16:42
MHDA- 2023/11/29 06:42
CRDT- 2023/10/07 11:08
PHST- 2023/09/26 00:00 [accepted]
PHST- 2023/11/29 06:42 [medline]
PHST- 2023/10/07 16:42 [pubmed]
PHST- 2023/10/07 11:08 [entrez]
AID - 10.1007/s11886-023-01973-9 [pii]
AID - 10.1007/s11886-023-01973-9 [doi]
PST - ppublish
SO  - Curr Cardiol Rep. 2023 Nov;25(11):1611-1622. doi: 10.1007/s11886-023-01973-9. 
      Epub 2023 Oct 7.